Characterization of AT2 receptor expression in NIH 3T3 fibroblasts

Cellular and Molecular Neurobiology

Volumn 19, Issue 2, 1999, Pages 277-288

  Heemskerk, Frank M J ^a   Zorad, Stefan ^a   Xu, Ningzhi ^b   Gutkind, Silvio J ^b   Saaredra, Juan M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

AT2 receptor; Cell cell contact: angiotensin converting enzyme; Growth curve; Neoplastic transformation; NIH3T3 fibroblasts

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; DITHIOTHREITOL; GUANINE NUCLEOTIDE BINDING PROTEIN; LOSARTAN; ADENOSINE 5' O (3 THIOTRIPHOSPHATE); ADENOSINE 5'-O-(3-THIOTRIPHOSPHATE); ADENOSINE TRIPHOSPHATE; ANGIOTENSIN II; ANGIOTENSIN II, SAR(1); ANGIOTENSIN II, SAR(1)-; ANGIOTENSIN RECEPTOR; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); GUANOSINE TRIPHOSPHATE; RADIOACTIVE IODINE;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL CONTACT; CELL DENSITY; CELL FUNCTION; CELL GROWTH; ENZYME ACTIVITY; FIBROBLAST; GENE EXPRESSION; GRANULAR CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIGAND BINDING; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; RECEPTOR BINDING; AFFINITY LABELING; ANIMAL; BINDING COMPETITION; CELL COMMUNICATION; CELL DIVISION; CELL STRAIN 3T3; CHEMISTRY; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENETIC TRANSFORMATION; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY;

3T3 CELLS; ADENOSINE TRIPHOSPHATE; AFFINITY LABELS; ANGIOTENSIN II; ANIMALS; BINDING, COMPETITIVE; CELL COMMUNICATION; CELL DIVISION; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); GUANOSINE TRIPHOSPHATE; IODINE RADIOISOTOPES; MICE; PEPTIDYL-DIPEPTIDASE A; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; TRANSFORMATION, GENETIC;

EID: 0032587748     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006985329240     Document Type: Article

References (39)

1. Bottari, S. P., de Gasparo, M., Steckelings, U. M., and Levens, N. R. (1993). Angiotensin II receptor subtypes: Characterization, signalling mechanisms, and possible physiological implications. Frontiers Neuroendocrinol. 14:123-171.
2. Bumpus, F. M., Catt, K. J., Chiu, A. T., de Gasparo, M., Goodfriend, T., Husain, A., Peach, M. J., Taylor, D. G., Jr., and Timmermans, P. B. M. W. M. (1991). Nomenclature for angiotensin receptors: A report of the nomenclature committee of the council for high blood pressure research. Hypertension 17:720-723.
3. Chiu, A. T., Duncia, J. V., McCall, D. E., Wong, P. C., Price, W. A., Thoolen, M. J. M. C., Carini, D. J., Johnson, A. L., and Timmermans, P. B. M. W. M. (1989a). Nonpeptide angiotensin II receptor antagonists. III. Structure-function studies. J. Pharmacol. Exp. Ther. 250:867-874.
4. Chiu, A. T., Herblin, W. F., McCall, D. E., Ardecky, R. J., Carini, D. J., Duncia, J. V., Pease, L. J., Wong, P. C., Wexler, R. R., Johnson, A. L., and Timmermans, P. B. M. W. M. (1989b). Identification of angiotensin II receptor subtypes. Biochem. Biophys. Res. Commun. 165:196-203.
5. de Gasparo, M., Husain, A., Alexander, W., Catt, K. J., Chiu, A. T., Drew, M., Goodfriend, T., Harding, J. W., Inagami, T., and Timmermans, P. B. M. W. M. (1995). Proposed update of angiotensin receptor nomenclature. Hypertension 25:924-927.
6. 2) binding sites in R3T3 cells. Regul Peptides 11:13-28.
7. 2) binding sites in R3T3 cells. Mol. Pharmacol. 40:360-367.
8. Dzau, V. J., Sasamura, H., and Hein, L. (1993). Heterogeneity of angiotensin synthetic pathways and receptor subtypes: Physiological and pharmacological implications. J. Hypertens. 11:S13-S18.
9. Griendling, K. K., Murphy, T. J., and Alexander, R. W. (1993). Molecular biology of the renin-angiotensin system. Circulation 87:1816-1828.
10. Harada, H., Kitagawa, M., Tanaka, N., Yamamoto, H., Harada, K., Ishihara, M., and Taniguchi, T. (1993). Anti-oncogenic and oncogenic potentials of transcriptional regulators IRF-1 and -2. Science 259:971-974.
11. Hopper, N. M. (1991). Angiotensin converting enzyme: Implications from molecular biology for its physiological functions. Int. J. Biochem. 23:641-647.
12. Horiuchi, M., Koike, G., Yamada, T., Mukoyama, M., Nakajima, M., and Dzau, V. J. (1995). The growth-dependent expression of angiotensin II type 2 receptor is regulated by transcription factors interferon regulatory factor-1 and -2 J. Biol. Chem. 270:20225-20230.
13. Ichiki, T., Kambayashi, Y., and Inagami, T. (1995). Multiple growth factors modulate mRNA expression of angiotensin of angiotensin II type-2 receptor in R3T3 cells. Cir. Res. 77:1070-1076.
14. Inagami, T., and Harris, R. C. (1993). Molecular insights into angiotensin II receptor subtypes. TIPS 8:215-218.
15. Jainchill, J. L., Aaronson, S. A., and Todaro, G. J. (1969). Murine sarcoma and leukemia virus: Assay using clonal lines of contact-inhibited mouse cells. J. Virol. 4:549-553.
16. Kalinec, G., Nazarali, A. J., Hermouet, S., Xu, N., and Gutkind, J. S., (1992). Mutated Ó subunit of the Gq protein induces malignant transformation in NIH 3T3 cells. Mol. Cell. Biol. 12:4687-4693.
17. Kambayashi, Y., Bardhan, S., and Inagami, T. (1993a). Peptide growth factors markedly decrease the ligand binding of angiotensin II type 2 receptor in rat cultured vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 194:478-482.
18. Kambayashi, Y., Bardhan, S., Takahashi, K., Tsuzuki, S., Inui, H., Hamakubo, T., and Inagami, T. (1993b). Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J. Biol. Chem. 268:24543-24546.
19. Krulewitz, A. H., Baur, W. E., and Fanburg, B. L. (1984). Hormonal influence on endothelial cell angiotensin-converting enzyme activity. Am. J. Physiol. 247:C163-C168.
20. 2) binding sites in the rat pheochromo-cytoma PC12W cells. Eur. J. Pharmacol. 227:63-67.
21. 2 receptor subtypes in the rat superior colliculus following eye enucleation. Neuroscience 58:835-844.
22. Mukoyama, M., Nakajima, M., Horiuchi, M., Sasamura, H., Pratt, R. E., and Dzau, V. J. (1993). Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven transmembrane receptors. J. Biol. Chem. 268:24539-24542.
23. Munson, P. J. (1983). LIGAND: A computerized analysis of ligand binding data. In Methods in Enzymology, (Langone, J. J., and Van Vunakis, H., eds.), Academic Press, New York, Vol. 92, Part E, pp. 543-576. 1983.
24. 2 receptor: Searching for signal-transduction pathways and physiological function. Trends Pharmacol. Sci. 16:223-225.
25. Nunes-Mamede, M. L., De Mello, F. G., and Martins, A. R. (1990). In ovo and in culture development of chick retinal angiotensin converting enzyme. Neurosci. Lett. 109:174-179.
26. Powell, J., Clozel, J. P., Muller, R. K. M., Kuhn, H., Hefti, F., Hosang, M., and Baumgartner, H. R. (1989). Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 245:186-188.
27. Pucell, A. G., Hodges, J. C., Sen, I., Bumpus, F. M., and Husain, A. (1991). Biochemical properties of the ovarian granulosa cell type 2-angiotensin II receptor. Endocrinology 128:1947-1959.
28. Rorhbach, M. S. (1978). [Glycine-1-14]hippuryl-histidyl-L-leucine: A substrate for the radiochemical assay of angiotensin-converting-enzyme. Anal. Biochem. 84:272-276.
29. Saavedra, J. M. (1992). Brain and pituitary angiotensin. Endocr. Rev. 13:329-380.
30. Schelling, P., Fischer, H., and Ganten, D. (1991). Angiotensin and cell growth: A link to cardiovascular hypertrophy. J. Hypertens. 9:3-15.
31. Shai, S.-Y., Fishel, R. S., Martin, B. M., Berk, B. C., and Bernstein, K. E. (1992). Bovine angiotensin converting enzyme cDNA cloning and regulation. Circ. Res. 70:1274-1281.
32. 2 receptors on Swiss 3T3 cells. Biochem. Mol. Biol. Int. 31:975-982.
33. 2-receptor medites inhibition of cell proliferation in coronary endothelial cells. J. Clin. Invest. 95:651-657.
34. Tanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T. W., and Taniguchi, T. (1994). Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77:829-839.
35. Tang, S.-S., Rogg, H., Schumacher, R., and Dzau, V. J. (1992). Characterization of nuclear angiotensin II binding sites in rat liver and comparison with plasma membrane receptors. Endocrinology 131:374-380.
36. Timmermans, P. B. M. W. M., Wong, P. C., Chiu, A. T., Herblin, W. F., Benfield, P., Carini, D. J., Lee, R. J., Wexler, R. R., Saye, J. A. M., and Smith, R. D. (1993). Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev. 45:205-251.
37. 2 receptors in the rat brain. Mol. Pharmacol. 41:290-297.
38. Whitebread, S., Mele, M., Kamber, B., and de Gasparo, M. (1989). Preliminary biochemical characterization of two angiotensin receptor subtypes. Biochem. Biophys. Res. Commun. 163:284-291.
39. Yang, H. Y. T., and Neff, N. H. (1973). Differential distribution of angiotensin-converting enzyme in the anterior and posterior lobe of the rat pituitary. J. Neurochem. 21:1035-1036.